Skip to main content
OpenTrials

Clinical trial condition

Paramyxoviridae Infections

Explore clinical trials studying Paramyxoviridae Infections. Study availability and eligibility vary by location and protocol.

354 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Paramyxoviridae Infections trial results

Completed

A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years

NCT06573281

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Rolling Hills Estates, California, United States
  • GSK Investigational Site Atlanta, Georgia, United States
  • GSK Investigational Site Lenexa, Kansas, United States
  • GSK Investigational Site Omaha, Nebraska, United States
View Trial Details
Completed

Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID/ΔM2-2/1030s, in RSV-Seronegative Infants and Children 6 to 24 Months of Age

NCT04520659

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations
  • John Hopkins Bloomberg School of Public Health Baltimore, Maryland, United States
  • University of Rochester Medical Center Rochester, New York, United States
  • Vanderbilt University Nashville, Tennessee, United States
View Trial Details
Completed

A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD)

NCT06614725

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Kanpur, Uttar Pradesh, India
  • GSK Investigational Site Ahmedabad, India
  • GSK Investigational Site Ahmedabad, India
  • GSK Investigational Site Aligarh, India
View all 14 locations
View Trial Details
Completed

Performance Evaluation of LumiraDx SARS-CoV-2, Flu A/B, and RSV Tests for COVID-19 Assessment

NCT05268939

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +16 more
Locations
  • Cullman Clinical Trials Cullman, Alabama, United States
  • Diagnamics, Inc Encinitas, California, United States
  • Marisela Gonzalez, MD, PA Miami, Florida, United States
  • Excellence Medical and Research Miami Gardens, Florida, United States
View Trial Details

Related conditions